Insulin Glargine vs Trastuzumab
Insulin Glargine vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Insulin Glargine and Trastuzumab.
Mechanism of Action
Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Insulin Glargine — 12-24 hours; Trastuzumab — 28 days.
Chemical Properties
Type: Insulin Glargine — Protein; Trastuzumab — Antibody.